Arkolith/Insider Trading/COYA/Form 4

Swaminathan Arun

Chief Executive Officer, DirectorCoya Therapeutics, Inc. (COYA) · full profile →Form 4 · filed Nov 13, 2024
Net Buying
Open-Market Buys
$37K
Open-Market Sells
$0
Net Open-Market Flow
$37K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 13, 2024Buy(P)5K$7.36$37K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-045120) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML